Institution: Santen Pharmaceutical

0:00:44

Santen Pharma

0:03:28

Radhika Tunstall, MD, PhD (Santen) Interview from the 4th annual Glaucoma Patient Summit

0:04:24

Industry funded PhD, Santen, Dr William Lamb

0:03:50

Vice President, Ophthalmology External Research, Santen Inc., Dr Naj Sharif

0:06:40

Pharma Trackts! 2017: Interview with Pasi Kemppainen, Santen Pharmaceutical

0:01:49

Glaucoma 360: New developments in pharma (Ellie Chabi, MD; (Santen, Inc)

0:01:26

Santen - Partnership with IPAO for the Dry Eye Management Institute project

0:03:34

Corporate Movie

0:00:33

Uveitis Industry 2018 Global Therapeutic Landscape Top Companies Research Institutes

0:10:14

NPC 2018 - Carol Stiff Presentation

0:05:40

Building a High-Performing Life Sciences Supply Chain Team

0:01:57

jCell: allogeneic cell therapy for retinitis pigmentosa

0:29:16

Corporate Venture Panel: The role of strategics in fueling innovation in ophthalmology

0:11:44

NABA 2015 Art Santen 1 of 2

0:02:09

Research projects within the EN-ACTI2NG program

0:02:27

Advanced therapies for retinitis pigmentosa

0:02:02

Research projects within the EN-ACTI2NG program

0:00:33

Ujin v Zamke - Finland

0:20:07

Cure Pharmaceuticals Presentation

0:01:00

Referentie project Produlab Pharma

0:01:19

Global Allergic Conjunctivitis Market Size

0:02:43

Ayushakti Manufaktur

0:42:30

SPCs and data exclusivity – The Northern Ireland Protocol makes an impact

0:04:03

Pravin Dugel, EURETINA 2018 – Brolucizumab For Neovascular Age-related Macular Degeneration